Variant report
Variant | esv2520305 |
---|---|
Chromosome Location | chr6:77279731-77281123 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188345250 | chr6:77279738-77279739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs576104287 | chr6:77279770-77279771 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs12202087 | chr6:77279858-77279859 | Weak transcription Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs556777019 | chr6:77279863-77279864 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs574835769 | chr6:77279870-77279871 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs192832376 | chr6:77279930-77279931 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs184672816 | chr6:77279952-77279953 | Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs540929765 | chr6:77280007-77280008 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs9361083 | chr6:77280008-77280009 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs147626686 | chr6:77280023-77280024 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs551580848 | chr6:77280035-77280036 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs371261447 | chr6:77280044-77280045 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs189385033 | chr6:77280055-77280056 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs113158905 | chr6:77280104-77280105 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs374637789 | chr6:77280114-77280115 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs55892849 | chr6:77280115-77280116 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs567103561 | chr6:77280142-77280143 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs534618487 | chr6:77280203-77280204 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs117402361 | chr6:77280257-77280258 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs566027009 | chr6:77280259-77280260 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs539769449 | chr6:77280342-77280343 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs545458790 | chr6:77280379-77280380 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs76913289 | chr6:77280396-77280397 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs118179760 | chr6:77280403-77280404 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs4441926 | chr6:77280443-77280444 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs555841748 | chr6:77280493-77280494 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs183749268 | chr6:77280528-77280529 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs375121868 | chr6:77280557-77280558 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs563611386 | chr6:77280559-77280560 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs541414997 | chr6:77280560-77280561 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs370078824 | chr6:77280613-77280614 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs58289412 | chr6:77280641-77280642 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs533249467 | chr6:77280647-77280648 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs374770845 | chr6:77280682-77280683 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs543090186 | chr6:77280761-77280762 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs148316563 | chr6:77280772-77280773 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs180924440 | chr6:77280781-77280782 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs548761547 | chr6:77280795-77280796 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs567342557 | chr6:77280816-77280817 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs372133537 | chr6:77280867-77280868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs528218852 | chr6:77280912-77280913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs562011654 | chr6:77280956-77280957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs546164355 | chr6:77281017-77281018 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs141427604 | chr6:77281109-77281110 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs79437427 | chr6:77281116-77281117 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs4404743 | chr6:77281122-77281123 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Developmental delay | 21147756 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Lung cancer | 16773561 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Prostate cancer | 16461572 | CNVD |
Mental retardation | 21045960 | CNVD |
Obesity | 21045960 | CNVD |
learning difficulties | 21045960 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:77274400-77284600 | Weak transcription | H9 Cell Line | embryonic stem cell |
2 | chr6:77277000-77279800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
3 | chr6:77277200-77280200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
4 | chr6:77277200-77284200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr6:77277600-77282600 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
6 | chr6:77277600-77284000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr6:77277600-77284400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
8 | chr6:77278400-77280600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
9 | chr6:77278400-77284200 | Weak transcription | H1 Cell Line | embryonic stem cell |
10 | chr6:77278600-77282400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
11 | chr6:77279800-77280000 | Genic enhancers | iPS-18 Cell Line | embryonic stem cell |
12 | chr6:77280000-77280200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
13 | chr6:77280200-77280800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr6:77280200-77283400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
15 | chr6:77280600-77280800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
16 | chr6:77280800-77281400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
17 | chr6:77280800-77281400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
18 | chr6:77281000-77282000 | Enhancers | HUES48 Cell Line | embryonic stem cell |